One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors
Read more
Home »
insights from industryDr. Marcos Quintela VasquezResearch and Development Innovation OfficerRBGO Research Group In this interview, News-Medical talks to Dr. Marcos
Read more
Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2
Read more
In a proof-of-concept study, an international scientific team led by Johns Hopkins Kimmel Cancer Center researchers has shown that a
Read more
A modelling study published in The Lancet Oncology journal estimates that there are almost 400,000 new cases of childhood cancer
Read more
MYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers. While MYC programs breast cancer
Read more
Women may not need to undergo surgery for non-cancerous ovarian cysts, avoiding potential surgical complications. This is the finding of
Read more
The most comprehensive genome-wide association study, or GWAS, of colorectal cancer risk to date, published today in Nature Genetics, has
Read more